FDA Considers Johnson & Johnson COVID-19 Vaccine For Emergency Use Authorization

An advisory committee to the Food and Drug Administration met to consider the application for emergency use authorization for the Janssen, the vaccine division of Johnson & Johnson, COVID-19 vaccine.

Comments

Popular posts from this blog

FIVE SIGNS YOUR TEEN MAY NEED TO BE EVALUATED FOR DEPRESSION

6 TIPS TO ESTABLISHING & MAINTAINING BREASTMILK SUPPLY WITH A NEWBORN

GETTING BACK TO SCHOOL SAFELY